FDA Commissioner Nomination Hearing Scheduled By Senate Health Committee
This article was originally published in The Pink Sheet Daily
Executive Summary
Nomination of FDA Acting Commissioner von Eschenbach to the post will be reviewed Aug. 1, although a vote is not anticipated.
You may also be interested in...
FDA Invites Barr To Discuss Plan B Switch: No Rulemaking Required
The OTC switch of Barr's emergency contraceptive could be "wrapped up in a matter of weeks," perhaps allowing confirmation of von Eschenbach to proceed.
FDA Invites Barr To Discuss Plan B Switch: No Rulemaking Required
The OTC switch of Barr's emergency contraceptive could be "wrapped up in a matter of weeks," perhaps allowing confirmation of von Eschenbach to proceed.
Will FDA Need A Plan B? Von Eschenbach Hold Exemplifies Agency Politicization, Critics Say
FDA risks losing credibility if agency continues to step outside its regulatory limits, panel at FDLI annual conference says.